Sulfabenzamide structure
|
Common Name | Sulfabenzamide | ||
---|---|---|---|---|
CAS Number | 127-71-9 | Molecular Weight | 276.311 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C13H12N2O3S | Melting Point | 180-184 °C | |
MSDS | Chinese USA | Flash Point | N/A |
Use of SulfabenzamideSulfabenzamide is a intermediate in the synthesis of organic and pharmaceutical. |
Name | Sulfabenzamide |
---|---|
Synonym | More Synonyms |
Description | Sulfabenzamide is a intermediate in the synthesis of organic and pharmaceutical. |
---|---|
Related Catalog |
Density | 1.4±0.1 g/cm3 |
---|---|
Melting Point | 180-184 °C |
Molecular Formula | C13H12N2O3S |
Molecular Weight | 276.311 |
Exact Mass | 276.056854 |
PSA | 97.64000 |
LogP | 1.19 |
Index of Refraction | 1.636 |
Storage condition | 2-8°C |
Water Solubility | 0.3 g/L (20 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Hazard Codes | N |
Safety Phrases | S22-S24/25 |
RIDADR | 3249 |
WGK Germany | 3 |
RTECS | CV5802500 |
Packaging Group | III |
Hazard Class | 6.1(b) |
HS Code | 2934999090 |
HS Code | 2924299090 |
---|---|
Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
J. Sci. Ind. Res. 65(10) , 808, (2006) Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ... |
|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Chem. Res. Toxicol. 23 , 1215-22, (2010) Drug-induced liver injury is a major issue of concern and has led to the withdrawal of a significant number of marketed drugs. An understanding of structure-activity relationships (SARs) of chemicals ... |
|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Drug Metab. Dispos. 38 , 2302-8, (2010) Drug-induced liver injury (DILI) is one of the most important reasons for drug development failure at both preapproval and postapproval stages. There has been increased interest in developing predicti... |
Benzamide, N-[(4-aminophenyl)sulfonyl]- |
N-[(4-Aminophenyl)sulfonyl]benzamide |
N-(4-Aminobenzenesulfonyl)benzamide |
4-Amino-N-benzoylbenzenesulfonamide |
N-Benzoylsulfanilamide |
Sulfabenzamide |
N-(4-aminophenyl)sulfonylbenzamide |
MFCD00044890 |
Sulfabenzamide(SB) |
Sultrin |
EINECS 204-859-4 |